Clinical Trials Directory

Trials / Completed

CompletedNCT04709289

Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne Vulgaris: a Prospective Study

Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Shanghai Dermatology Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To understand, prevent and treat the adverse reactions more comprehensively, we sought to systemically document the adverse effects of ALA-PDT for moderate to severe acne vulgaris.

Detailed description

To understand, prevent and treat the adverse reactions more comprehensively, we sought to systemically document the adverse effects of ALA-PDT for moderate to severe acne vulgaris.

Conditions

Interventions

TypeNameDescription
OTHERAminolevulinic acid, photodynamic therapyAminolevulinic acid, photodynamic therapy

Timeline

Start date
2020-01-01
Primary completion
2020-01-01
Completion
2020-02-28
First posted
2021-01-14
Last updated
2021-01-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04709289. Inclusion in this directory is not an endorsement.

Adverse Effects of ALA-PDT for the Treatment of Moderate to Severe Acne Vulgaris: a Prospective Study (NCT04709289) · Clinical Trials Directory